NCT06976073 2025-05-16
Spectrum1
HJN Sverige AB/Neko Health
Recruiting
Clinical Trials
6 trialsNCT06709040 2025-02-05
A Study to Follow Paediatric Participants With Growth Hormone Deficiency Treated With Somapacitan for Long Term Safety Information and Clinical Parameters
Novo Nordisk A/S
Enrolling by invitation
NCT04572165 2024-01-02
Epidemiological Assessment of the Risk for Pancreatic Cancer Associated With the Use of Semaglutide in Patients With Type 2 Diabetes - A Cohort Study Based on Nordic Registry Data
Novo Nordisk A/S
Unknown
NCT01511393 2023-06-13
An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC)
Novo Nordisk A/S
Enrolling by invitation
NCT02608853 2015-11-20
Estimation of Malignancy Rates Within Humedica Patient Populations Sampled to be Representative of Liraglutide Initiators and LEADERâ„¢ Trial Participants
Novo Nordisk A/S
Completed
NCT01195259 2013-10-28
Malignancy Meta Analysis for BRL49653
GlaxoSmithKline
Completed